CX-908

N/A

Report date: 2025/12/01 11:40:02

Base Information

Drug NameCX-908
Drug Alias NameCX-908
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionCadherin 3 inhibitors
TargetsCadherin 3
Therapy Area/IndicationsLung NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCytomx Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCytomx Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A